BNET Industries

Xoma

(XOMA) is in the Pharma Industry

Market Cap:$163.4M
Last Fiscal Year Sales:$67.9M
  • Public
  • US
Dow Jones Description

XOMA's platform technologies for the development, scale-up and manufacture of biological therapeutic compounds, particularly monoclonal antibodies, makes us an ideal partner to government entities to speed the advancement of defenses against emerging pathogens. We currently have ongoing contracts with the National Institutes of Health (NIH), National Institute of Allergy and Infectious Disease (NIAID) to develop monoclonal antibody products to the botulinum neurotoxin produced by the bacterial Clostridium botulinum. As part of our work on the Botulinum biodefense program, XOMA developed novel antibody formulations comprised of multiple antibodies, each one specific to a particular portion of the lethal neurotoxin. XOMA also completed the production and filling of clinical supplies that are intended for use in the clinical development of the product. We are also assessing how the expertise and capabilities used in our anti-botulinum programs can address other major biodefense needs in the U.S. and other countries.

Number of Employees 335
Contact Information

2910 7th St

Berkeley, California 94710-2700

xoma.com

1 858 720 8797

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Recent Events

  • Canaccord Adams Initiates Coverage on XOMA XOMA with a Buy; XOMA-052 Promising New Type 2...

    11/18/09 - Bond / Stock Rating - View Story

  • XOMA Appoints Jim Neal Vice President of Business Development

    11/17/09 - Mgmt. Change Entering - Business Development - View Story

  • Xoma lands $8M in R&D technology deal

    11/03/09 - New Investment - View Story

  • XOMA Reports 2009 Third Quarter Financial Results

    11/10/09 - Financial Announcement - View Story

  • XOMA names Susan Kramer VP project, alliance management

    10/14/09 - Mgmt. Change Entering - Vice President - View Story

  • PicksThatMove: www.PicksThatMove.com: "Picks that move" Alerts, October 14, 2009: XOMA, LOCM, UNFY, ILMN, LUFK and...

    10/14/09 - Mgmt. Change Entering - Other - View Story

  • BRIEF-XOMA announces $13.9 mln financing

    9/30/09 - New Investment - View Story

  • STOCKS NEWS US-Rep Frank: financial reform 'will be done'

    9/14/09 - New Investment - View Story

  • XOMA announces antibody discovery collaboration with Arana Therapeutics

    9/10/09 - Joint Venture / Alliance - View Story

  • XOMA Reports 2009 Second Quarter Financial Results

    8/07/09 - Financial Announcement - View Story

News & Analysis

xoma - All News and Analysis

advertisement
     XOMA $0.73 0.00 (0.00% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 3,681,730
Shares Outstanding 101.50M
Market Cap 74.1M
Year High 1.34
Year Low 0.37
Earnings Per Share N/A
P/E Ratio -
Dividend N/A
Yield N/A
IndustryTop Rated
advertisement